Q Fever as a Cause of Community-Acquired Pneumonia in French Guiana. 2022

Loïc Epelboin, and Aba Mahamat, and Timothée Bonifay, and Magalie Demar, and Philippe Abboud, and Gaëlle Walter, and Anne-Sophie Drogoul, and Alain Berlioz-Arthaud, and Mathieu Nacher, and Didier Raoult, and Félix Djossou, and Carole Eldin
Infectious and Tropical Diseases Department, Centre Hospitalier de Cayenne Andrée Rosemon, Cayenne, French Guiana.

In French Guiana, community-acquired pneumonia (CAP) represents over 90% of Coxiella burnetii acute infections. Between 2004 and 2007, we reported that C. burnetii was responsible for 24.4% of the 131 CAP hospitalized in Cayenne. The main objective of the present study was to determine whether the prevalence of Q fever pneumonia remained at such high levels. The secondary objectives were to identify new clinical characteristics and risk factors for C. burnetii pneumonia. A retrospective case-control study was conducted on patients admitted in Cayenne Hospital, between 2009 and 2012. All patients with CAP were included. The diagnosis of acute Q fever relied on titers of phase II IgG ≥ 200 and/or IgM ≥ 50 or seroconversion between two serum samples. Patients with Q fever were compared with patients with non-C. burnetii CAP in bivariate and multivariate analyses. During the 5-year study, 275 patients with CAP were included. The etiology of CAP was identified in 54% of the patients. C. burnetii represented 38.5% (106/275; 95% CI: 31.2-45.9%). In multivariate analysis, living in Cayenne area, being aged 30-60 years, C-reactive protein (CRP) > 185 mg/L, and leukocyte count < 10 G/L were independently associated with Q fever. The prevalence of Q fever among CAP increased to 38.5%. This is the highest prevalence ever reported in the world. This high prevalence justifies the systematic use of doxycycline in addition to antipneumococcal antibiotic regimens.

UI MeSH Term Description Entries
D011014 Pneumonia Infection of the lung often accompanied by inflammation. Experimental Lung Inflammation,Lobar Pneumonia,Lung Inflammation,Pneumonia, Lobar,Pneumonitis,Pulmonary Inflammation,Experimental Lung Inflammations,Inflammation, Experimental Lung,Inflammation, Lung,Inflammation, Pulmonary,Inflammations, Lung,Inflammations, Pulmonary,Lobar Pneumonias,Lung Inflammation, Experimental,Lung Inflammations,Lung Inflammations, Experimental,Pneumonias,Pneumonias, Lobar,Pneumonitides,Pulmonary Inflammations
D011778 Q Fever An acute infectious disease caused by COXIELLA BURNETII. It is characterized by a sudden onset of FEVER; HEADACHE; malaise; and weakness. In humans, it is commonly contracted by inhalation of infected dusts derived from infected domestic animals (ANIMALS, DOMESTIC). Coxiella burnetii Fever,Query Fever,Acute Q Fever,Chronic Q Fever,Coxiella burnetii Infection,Coxiella burnetii Vector-Borne Disease,Acute Q Fevers,Chronic Q Fevers,Coxiella burnetii Fevers,Coxiella burnetii Infections,Coxiella burnetii Vector Borne Disease,Fever, Acute Q,Fever, Chronic Q,Fever, Coxiella burnetii,Fever, Q,Fever, Query,Fevers, Acute Q,Fevers, Chronic Q,Fevers, Coxiella burnetii,Fevers, Q,Fevers, Query,Infection, Coxiella burnetii,Infections, Coxiella burnetii,Q Fever, Acute,Q Fever, Chronic,Q Fevers,Q Fevers, Acute,Q Fevers, Chronic,Query Fevers
D005616 French Guiana A French overseas department on the northeast coast of South America. Its capital is Cayenne. It was first settled by the French in 1604. Early development was hindered because of the presence of a penal colony. The name of the country and the capital are variants of Guyana, possibly from the native Indian Guarani guai (born) + ana (kin), implying a united and interrelated race of people. (From Webster's New Geographical Dictionary, 1988, p418 & Room, Brewer's Dictionary of Names, 1992, p195)
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control
D016997 Coxiella burnetii A species of gram-negative bacteria that grows preferentially in the vacuoles of the host cell. It is the etiological agent of Q FEVER.
D017714 Community-Acquired Infections Any infection acquired in the community, that is, contrasted with those acquired in a health care facility (CROSS INFECTION). An infection would be classified as community-acquired if the patient had not recently been in a health care facility or been in contact with someone who had been recently in a health care facility. Community Acquired Infection,Community-Acquired Infection,Infections, Community-Acquired,Acquired Infection, Community,Acquired Infections, Community,Community Acquired Infections,Infection, Community Acquired,Infection, Community-Acquired,Infections, Community Acquired

Related Publications

Loïc Epelboin, and Aba Mahamat, and Timothée Bonifay, and Magalie Demar, and Philippe Abboud, and Gaëlle Walter, and Anne-Sophie Drogoul, and Alain Berlioz-Arthaud, and Mathieu Nacher, and Didier Raoult, and Félix Djossou, and Carole Eldin
October 2014, The American journal of tropical medicine and hygiene,
Loïc Epelboin, and Aba Mahamat, and Timothée Bonifay, and Magalie Demar, and Philippe Abboud, and Gaëlle Walter, and Anne-Sophie Drogoul, and Alain Berlioz-Arthaud, and Mathieu Nacher, and Didier Raoult, and Félix Djossou, and Carole Eldin
March 1957, Publication. Cayenne, French Guiana. Institut Pasteur de la Guyane francaise et de l'Inini,
Loïc Epelboin, and Aba Mahamat, and Timothée Bonifay, and Magalie Demar, and Philippe Abboud, and Gaëlle Walter, and Anne-Sophie Drogoul, and Alain Berlioz-Arthaud, and Mathieu Nacher, and Didier Raoult, and Félix Djossou, and Carole Eldin
January 1998, Emerging infectious diseases,
Loïc Epelboin, and Aba Mahamat, and Timothée Bonifay, and Magalie Demar, and Philippe Abboud, and Gaëlle Walter, and Anne-Sophie Drogoul, and Alain Berlioz-Arthaud, and Mathieu Nacher, and Didier Raoult, and Félix Djossou, and Carole Eldin
November 1996, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses,
Loïc Epelboin, and Aba Mahamat, and Timothée Bonifay, and Magalie Demar, and Philippe Abboud, and Gaëlle Walter, and Anne-Sophie Drogoul, and Alain Berlioz-Arthaud, and Mathieu Nacher, and Didier Raoult, and Félix Djossou, and Carole Eldin
September 2014, Epidemiology and infection,
Loïc Epelboin, and Aba Mahamat, and Timothée Bonifay, and Magalie Demar, and Philippe Abboud, and Gaëlle Walter, and Anne-Sophie Drogoul, and Alain Berlioz-Arthaud, and Mathieu Nacher, and Didier Raoult, and Félix Djossou, and Carole Eldin
January 2004, Paediatric respiratory reviews,
Loïc Epelboin, and Aba Mahamat, and Timothée Bonifay, and Magalie Demar, and Philippe Abboud, and Gaëlle Walter, and Anne-Sophie Drogoul, and Alain Berlioz-Arthaud, and Mathieu Nacher, and Didier Raoult, and Félix Djossou, and Carole Eldin
January 2024, Travel medicine and infectious disease,
Loïc Epelboin, and Aba Mahamat, and Timothée Bonifay, and Magalie Demar, and Philippe Abboud, and Gaëlle Walter, and Anne-Sophie Drogoul, and Alain Berlioz-Arthaud, and Mathieu Nacher, and Didier Raoult, and Félix Djossou, and Carole Eldin
August 2002, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
Loïc Epelboin, and Aba Mahamat, and Timothée Bonifay, and Magalie Demar, and Philippe Abboud, and Gaëlle Walter, and Anne-Sophie Drogoul, and Alain Berlioz-Arthaud, and Mathieu Nacher, and Didier Raoult, and Félix Djossou, and Carole Eldin
May 2014, The American journal of tropical medicine and hygiene,
Loïc Epelboin, and Aba Mahamat, and Timothée Bonifay, and Magalie Demar, and Philippe Abboud, and Gaëlle Walter, and Anne-Sophie Drogoul, and Alain Berlioz-Arthaud, and Mathieu Nacher, and Didier Raoult, and Félix Djossou, and Carole Eldin
March 2008, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society,
Copied contents to your clipboard!